Wired for What’s Next.
Reach your press release and disclosure targets.
Get more views with multimedia.
Track your results and refine your message.
Be the news everyone talks about.
Latest News
Today is March 28, 2024.
All times in Eastern Daylight Time.
-
Exchange Bank Announces Kevin Bender as Senior Vice President, Chief Banking OfficerSANTA ROSA, Calif.--(BUSINESS WIRE)--Exchange Bank Announces Kevin Bender as Senior Vice President, Chief Banking Officer more »
-
KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2024-3 (SEMT 2024-3)NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 55 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2024-3 (SEMT 2024-3), a $389.8 million prime RMBS transac... more »
-
Kenai Therapeutics anuncia financiamento de série A de US$ 82 milhões para avançar em terapias celulares alogênicas de última geração para doenças neurológicasSAN DIEGO--(BUSINESS WIRE)--A Kenai Therapeutics, uma empresa de biotecnologia que utiliza tecnologia de células-tronco pluripotentes induzidas (iPSC) para descobrir e desenvolver uma plataforma de... more »
-
Kenai Therapeutics annonce un financement de série A de 82 millions de dollars pour faire progresser les thérapies cellulaires allogéniques de nouvelle génération pour les maladies neurologiquesSAN DIEGO--(BUSINESS WIRE)--Kenai Therapeutics, une entreprise de biotechnologie exploitant la technologie de cellules souches pluripotentes induites (iPS) pour découvrir et développer une platefor... more »
-
Saint-Gobain: 2023 Annual ResultsCOURBEVOIE, France--(BUSINESS WIRE)--Benoit Bazin, Chief Executive Officer of Saint-Gobain, commented: “In a difficult macroeconomic environment with lower volumes, Saint-Gobain once again demonstr... more »
-
Argonne Upgrade Lets Data Portal Users Get NERDE about Economic ResilienceLEMONT, Ill.--(BUSINESS WIRE)--Argonne’s updated online data explorer provides community leaders and administrators with more accessible, easier-to-use economic development data more »
-
Riassunto: I trasportatori premier di FourKites registrano una crescita eccezionale nella seconda metà del 2023AMSTERDAM--(BUSINESS WIRE)--Il principale fornitore di visibilità delle catene di fornitura in tempo reale FourKites oggi ha pubblicato la sua Premier Carrier List (PCL), la lista dei migliori tras... more »
-
Resumen: Los principales transportistas de FourKites evidencian un impresionante crecimiento en el segundo semestre de 2023ÁMSTERDAM--(BUSINESS WIRE)--El proveedor de visibilidad de cadena de suministro en tiempo real líder, FourKites, publicó hoy su lista de principales transportistas (Premier Carrier List, PCL) globa... more »
-
Samenvatting: Premier Carriers van FourKites laten enorme groei zien in tweede helft van 2023AMSTERDAM--(BUSINESS WIRE)--FourKites, een toonaangevende leverancier van supply chain visibility in real time, heeft vandaag haar wereldwijde Premier Carrier List (PCL) gepubliceerd. Hiermee wordt... more »
-
Les premiers transporteurs FourKites enregistrent une croissance exceptionnelle au second semestre 2023AMSTERDAM--(BUSINESS WIRE)--Principal fournisseur de visibilité en temps réel de la chaîne d’approvisionnement, FourKites a publié aujourd’hui sa Premier Carrier List (PCL) mondiale, reconnaissant ... more »
-
Kenai Therapeutics宣布完成8200萬美元A輪融資,以推進用於神經系統疾病的下一代異體細胞療法聖地亞哥--(BUSINESS WIRE)--(美國商業資訊)-- Kenai Therapeutics,這家專注於運用誘導多能幹細胞(iPSC)技術開發一系列用於治療神經系統疾病的異體神經元替代細胞療法的生物技術公司,今日宣布已完成一筆8200萬美元的A輪融資。此輪融資由阿拉斯加永久基金公司、Cure Ventures和The Column Group共同領投,Euclidean Capi... more »
-
Kenai Therapeutics宣布获得8200万美元的A轮融资,以推动针对神经系统疾病的下一代同种异体细胞疗法圣迭戈--(BUSINESS WIRE)--(美国商业资讯)-- Kenai Therapeutics是一家生物科技公司,利用诱导性多能干细胞(iPSC)技术来发现和开发针对神经系统紊乱的同种异体神经元替换细胞疗法,该公司今天宣布获得8200万美元的A轮融资,由Alaska Permanent Fund Corporation、Cure Ventures和The Column Group联合... more »
-
Samenvatting: Kenai Therapeutics kondigt serie A-financiering van $ 82 miljoen aan ter bevordering van allogene celtherapieën van volgende generatie voor neurologische ziektenSAN DIEGO--(BUSINESS WIRE)--Kenai Therapeutics, een biotechnologiebedrijf dat gebruik maakt van geïnduceerde pluripotente stamceltechnologie (iPSC) om een platform van allogene neuronvervangende ce... more »
-
Riassunto: Kenai Therapeutics annuncia un finanziamento di serie A da 82 milioni di dollari per promuovere le terapie cellulari allogeniche di nuova generazione per malattie neurologicheSAN DIEGO--(BUSINESS WIRE)--Kenai Therapeutics, una società biotecnologica che utilizza la tecnologia delle cellule staminali pluripotenti indotte (iPSC) per scoprire e sviluppare una piattaforma d... more »
-
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased The Children’s Place, Inc. (“The Children’s ... more »